Furthermore, Kaplan-Meier survival analysis suggested that AML patients with high methylation level of TNFAIP2 at gene body (cg00731608, cg13144594 and cg08301307) exhibited inferior overall survival (OS) (Supplementary Fig. S2b). This evidence concerns the gene TNFAIP2 and acute myeloid leukemia.